Cargando…
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany
INTRODUCTION: Real-world evidence (RWE) data is increasingly important to generate rapid insights to effectively manage patient populations. Disruptions like the coronavirus disease 2019 (COVID-19) pandemic may negatively impact the choice of medications used for managing chronic diseases such as ps...
Autores principales: | Kahn, Maria, Papukchieva, Steffeni, Jacyshyn-Owen, Elizabeth, Grimm, Stefan, Eberl, Markus, Schneeweiss, Sebastian, Otten, Marina, Augustin, Matthias, Friedrich, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613167/ https://www.ncbi.nlm.nih.gov/pubmed/37710077 http://dx.doi.org/10.1007/s13555-023-01023-w |
Ejemplares similares
-
The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany
por: Orschiedt, Jonathan, et al.
Publicado: (2023) -
Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis
por: Kahn, Maria, et al.
Publicado: (2023) -
Correlation and differences of patient-reported outcomes vs.
Likert-Rating of MS symptoms in a real-world cohort using a digital patient
app
por: Mountford, Steffeni, et al.
Publicado: (2023) -
Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany
por: Balakrishnan, Preetha, et al.
Publicado: (2022) -
Real-world demographic patterns of users of a digital primary prevention service for diabetes
por: Balakrishnan, Preetha, et al.
Publicado: (2022)